Literature DB >> 11391734

Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease.

D Joel1.   

Abstract

The early stages of Huntington's disease (HD) present with motor, cognitive, and emotional symptoms. Correspondingly, current models implicate dysfunction of the motor, associative, and limbic basal ganglia-thalamocortical circuits. Available data, however, indicate that in the early stages of the disease, striatal damage is mainly restricted to the associative striatum. Based on an open interconnected model of basal ganglia-thalamocortical organization, we provide a detailed account of the mechanisms by which associative striatal pathology may lead to the complex pattern of motor, cognitive, and emotional symptoms of early HD. According to this account, the degeneration of a direct and several indirect pathways arising from the associative striatum leads to impaired functioning of: (1) the motor circuit, resulting in chorea and bradykinesia, (2) the associative circuit, resulting in abnormal eye movements, "frontal-like" cognitive deficits and "cognitive disinhibition," and (3) the limbic circuit, resulting in affective and psychiatric symptoms. When relevant, this analysis is aided by comparing the symptomatology of HD patients to that of patients with mild to moderate Parkinson's disease, since in the latter there is similar dysfunction of direct pathways but opposite dysfunction of indirect pathways. Finally, we suggest a potential novel treatment of HD and provide supportive evidence from a rat model of the disease. Copyright 2001 Movement Disorder Society.

Entities:  

Mesh:

Year:  2001        PMID: 11391734     DOI: 10.1002/mds.1096

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  36 in total

1.  Cognitive potentials in the basal ganglia-frontocortical circuits. An intracerebral recording study.

Authors:  Ivan Rektor; Martin Bares; Petr Kanovský; Milan Brázdil; Irena Klajblová; Hana Streitová; Irena Rektorová; Daniela Sochůrková; Dagmar Kubová; Robert Kuba; Pavel Daniel
Journal:  Exp Brain Res       Date:  2004-06-22       Impact factor: 1.972

2.  Structural analysis of the basal ganglia in schizophrenia.

Authors:  Daniel Mamah; Lei Wang; Deanna Barch; Gabriel A de Erausquin; Mokhtar Gado; John G Csernansky
Journal:  Schizophr Res       Date:  2006-10-30       Impact factor: 4.939

3.  Neural bases of dysphoria in early Huntington's disease.

Authors:  Sergio Paradiso; Beth M Turner; Jane S Paulsen; Ricardo Jorge; Laura L Boles Ponto; Robert G Robinson
Journal:  Psychiatry Res       Date:  2008-01-15       Impact factor: 3.222

Review 4.  Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.

Authors:  Antonio Alcaro; Robert Huber; Jaak Panksepp
Journal:  Brain Res Rev       Date:  2007-08-21

5.  Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease.

Authors:  Paul G Unschuld; Suresh E Joel; Xinyang Liu; Megan Shanahan; Russell L Margolis; Kevin M Biglan; Susan S Bassett; David J Schretlen; Graham W Redgrave; Peter C M van Zijl; James J Pekar; Christopher A Ross
Journal:  Neurosci Lett       Date:  2012-03-07       Impact factor: 3.046

6.  Connectivity of the subthalamic nucleus and globus pallidus pars interna to regions within the speech network: a meta-analytic connectivity study.

Authors:  Jordan L Manes; Amy L Parkinson; Charles R Larson; Jeremy D Greenlee; Simon B Eickhoff; Daniel M Corcos; Donald A Robin
Journal:  Hum Brain Mapp       Date:  2013-11-25       Impact factor: 5.038

7.  Huntington disease as a dual diagnosis disorder: data from the National Research Roster for Huntington disease patients and families.

Authors:  Jason C Ehret; Patricia S Day; Ryan Wiegand; Joanne Wojcieszek; R Andrew Chambers
Journal:  Drug Alcohol Depend       Date:  2006-08-22       Impact factor: 4.492

Review 8.  A scale-free systems theory of motivation and addiction.

Authors:  R Andrew Chambers; Warren K Bickel; Marc N Potenza
Journal:  Neurosci Biobehav Rev       Date:  2007-05-03       Impact factor: 8.989

Review 9.  Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action.

Authors:  Bernard W Balleine; John P O'Doherty
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

10.  Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease.

Authors:  Brooke R Snyder; Andrew M Chiu; Darwin J Prockop; Anthony W S Chan
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.